NISA INVESTMENT ADVISORS, LLC - IMMUNOGEN INC ownership

IMMUNOGEN INC's ticker is IMGN and the CUSIP is 45253H101. A total of 193 filers reported holding IMMUNOGEN INC in Q1 2023. The put-call ratio across all filers is 0.37 and the average weighting 0.1%.

Quarter-by-quarter ownership
NISA INVESTMENT ADVISORS, LLC ownership history of IMMUNOGEN INC
ValueSharesWeighting
Q3 2023$102,044
-16.1%
6,430
-0.3%
0.00%0.0%
Q2 2023$121,674
+552963.6%
6,448
+15.1%
0.00%
Q1 2023$22
-57.7%
5,600
-46.6%
0.00%
Q4 2022$52
-99.9%
10,490
-0.6%
0.00%
-100.0%
Q3 2022$63,000
+34.0%
10,554
+1.6%
0.00%
Q2 2022$47,000
+104.3%
10,390
+116.9%
0.00%
Q1 2022$23,000
-55.8%
4,790
-48.3%
0.00%
Q4 2021$52,000
-27.8%
9,260
-27.3%
0.00%
Q3 2021$72,000
-14.3%
12,7300.0%0.00%
-100.0%
Q2 2021$84,000
-18.4%
12,7300.0%0.00%0.0%
Q1 2021$103,000
+25.6%
12,7300.0%0.00%0.0%
Q4 2020$82,000
+645.5%
12,730
+320.1%
0.00%
Q3 2020$11,000
+22.2%
3,030
+48.5%
0.00%
Q2 2020$9,000
+80.0%
2,040
+27.5%
0.00%
Q1 2020$5,000
-37.5%
1,6000.0%0.00%
Q4 2019$8,000
+100.0%
1,6000.0%0.00%
Q3 2019$4,000
+33.3%
1,6000.0%0.00%
Q2 2019$3,000
-25.0%
1,6000.0%0.00%
Q1 2019$4,000
-98.2%
1,600
-96.5%
0.00%
-100.0%
Q4 2018$217,000
+3000.0%
45,300
+6063.3%
0.00%
Q3 2018$7,0000.0%735
+8.9%
0.00%
Q2 2018$7,0000.0%6750.0%0.00%
Q1 2018$7,000
-41.7%
675
-62.5%
0.00%
Q4 2017$12,000
+20.0%
1,800
+34.3%
0.00%
Q3 2017$10,0000.0%1,3400.0%0.00%
Q2 2017$10,000
+25.0%
1,340
-33.0%
0.00%
Q1 2017$8,0002,0000.00%
Other shareholders
IMMUNOGEN INC shareholders Q1 2023
NameSharesValueWeighting ↓
Redmile Group, LLC 3,984,734$15,421,0001.00%
Moloney Securities Asset Management, LLC 274,450$1,062,0000.55%
Schonfeld Strategic Advisors LLC 1,025,176$3,968,0000.40%
Orbimed Advisors 6,095,647$23,590,0000.27%
TWIN FOCUS CAPITAL PARTNERS, LLC 113,216$438,0000.26%
PINNACLE ASSOCIATES LTD 1,589,959$6,153,0000.12%
Baker Brothers Advisors 3,015,353$11,669,0000.10%
BAXTER BROS INC 58,000$224,0000.07%
SIMON QUICK ADVISORS, LLC 25,000$97,0000.06%
ClearBridge Investments 14,428,856$55,840,0000.06%
View complete list of IMMUNOGEN INC shareholders